Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引：0
作者：
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构：
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65041-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
  • [21] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [22] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [23] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [24] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [25] Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)
    Gerds, Aaron T.
    Gupta, Shaloo
    Binder, Gary
    Sekeres, Mikkael A.
    Nazha, Aziz
    Carraway, Hetty E.
    Hawthorne, Stephanie
    King-Concialdi, Kristen
    McGuire, Michael
    BLOOD, 2016, 128 (22)
  • [26] Thalidomide produces transfusion independence in patients with long-standing refractory anemias and myelodysplastic syndromes (MDS).
    Raza, A
    Lisak, L
    Andrews, C
    Little, L
    Muzammil, M
    Alvi, S
    Mazzoran, L
    Zorat, F
    Akber, A
    Ekbal, M
    Razvi, S
    Venugopal, P
    BLOOD, 1999, 94 (10) : 661A - 661A
  • [27] Cost analysis of long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS).
    Gupta, P
    LeRoy, SC
    Bateman, A
    Morrison, VA
    BLOOD, 1998, 92 (10) : 421A - 421A
  • [28] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [29] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [30] Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications
    Gupta, P
    LeRoy, SC
    Luikart, SD
    Bateman, A
    Morrison, VA
    LEUKEMIA RESEARCH, 1999, 23 (10) : 953 - 959
12345